Valeant Pharmaceuticals Completes Acquisition of Aton Pharma, Inc.

May 27, 2010

ALISO VIEJO, Calif., May 27, 2010 /PRNewswire via COMTEX/ --Valeant Pharmaceuticals International (NYSE: VRX) today announced that effective May 26, 2010, the company completed its acquisition of Aton Pharma, Inc., a specialty pharmaceutical company focused on ophthalmology and certain orphan drug indications, located in Lawrenceville, New Jersey.

About Valeant

Valeant Pharmaceuticals International (NYSE:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at

Laurie W. Little
Valeant Pharmaceuticals

Annual Report

2015 Annual Report

The right products
The right philosophy.
record organic growth.

View All